Dissociation between liver inflammation and hepatocellular damage induced by carbon tetrachloride in myeloid cell-specific signal transducer and activator of transcription 3 gene knockout mice

Hepatology

Volumn 51, Issue 5, 2010, Pages 1724-1734

  Horiguchi, Norio ^a   Lafdil, Fouad ^a   Miller, Andrew M ^a   Park, Ogyi ^a   Wang, Hua ^a   Rajesh, Mohanraj ^a   Mukhopadhyay, Partha ^a   Fu, Xin Yuan ^b   Pacher, Pal ^a   Gao, Bin ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON TETRACHLORIDE; INTERLEUKIN 6; STAT3 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; BONE MARROW CELL; CONTROLLED STUDY; DISSOCIATION; GENE DELETION; HEPATITIS; LIVER CELL DAMAGE; LIVER NECROSIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CARBON TETRACHLORIDE POISONING; HEPATOCYTES; INFLAMMATION; LIVER; MALE; MICE; MICE, KNOCKOUT; NECROSIS; OXIDATIVE STRESS; STAT3 TRANSCRIPTION FACTOR;

EID: 77951428317     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.23532     Document Type: Article

References (34)

1. Szabo G, Mandrekar P, Dolganiuc A. Innate immune response and hepatic inflammation. Semin Liver Dis 2007;27:339-350. (Pubitemid 350071835)
2. Ramaiah SK, Jaeschke H. Role of neutrophils in the pathogenesis of acute inflammatory liver injury. Toxicol Pathol 2007;35:757-766. (Pubitemid 47613608)
3. Eksteen B, Afford SC, Wigmore SJ, Holt AP, Adams DH. Immunemediated liver injury. Semin Liver Dis 2007;27:351-366.
4. Berasain C, Castillo J, Perugorria MJ, Latasa MU, Prieto J, Avila MA. Inflammation and liver cancer: new molecular links. Ann N Y Acad Sci 2009;1155:206-221.
5. Jaeschke H, Hasegawa T. Role of neutrophils in acute inflammatory liver injury. Liver Int 2006;26:912-919. (Pubitemid 44323408)
6. Mandrekar P, Szabo G. Signalling pathways in alcohol-induced liver inflammation. J Hepatol 2009;50:1258-1266.
7. Heydtmann M, Adams DH. Chemokines in the immunopathogenesis of hepatitis C infection. HEPATOLOGY 2009;49:676-688.
8. Ahmed A, Keeffe EB. Chronic hepatitis C with normal aminotransferase levels. Gastroenterology 2004;126:1409-1415. (Pubitemid 38552804)
9. Sanai FM, Benmousa A, Al-Hussaini H, Ashraf S, Alhafi O, Abdo AA, et al. Is serum alanine transaminase level a reliable marker of histological disease in chronic hepatitis C infection? Liver Int 2008;28:1011-1018.
10. Luo JC, Hwang SJ, Lai CR, Lu CL, Li CP, Tsay SH, et al. Relationships between serum aminotransferase levels, liver histologies and virological status in patients with chronic hepatitis C in Taiwan. J Gastroenterol Hepatol 1998;13:685-690.
11. Naito M, Hayashi N, Hagiwara H, Hiramatsu N, Kasahara A, Fusamoto H, et al. Serum hepatitis C virus RNA quantity and histological features of hepatitis C virus carriers with persistently normal ALT levels. HEPATOLOGY 1994;19:871-875. (Pubitemid 24109347)
12. Mofrad P, Contos MJ, Haque M, Sargeant C, Fisher RA, Luketic VA, et al. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. HEPATOLOGY 2003;37:1286-1292. (Pubitemid 36667307)
13. Fracanzani AL, Valenti L, Bugianesi E, Andreoletti M, Colli A, Vanni E, et al. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes. HEPATOLOGY 2008;48:792-798.
14. Basu S. Carbon tetrachloride-induced lipid peroxidation: eicosanoid formation and their regulation by antioxidant nutrients. Toxicology 2003;189:113-127. (Pubitemid 36725027)
15. Kovalovich K, DeAngelis RA, Li W, Furth EE, Ciliberto G, Taub R. Increased toxin-induced liver injury and fibrosis in interleukin-6- deficient mice. HEPATOLOGY 2000;31:149-159. (Pubitemid 30033701)
16. Gao B. Cytokines, STATs and liver disease. Cell Mol Immunol 2005;2:92-100.
17. Jin X, Zhang Z, Beer-Stolz D, Zimmers TA, Koniaris LG. Interleukin-6 inhibits oxidative injury and necrosis after extreme liver resection. HEPATOLOGY 2007;46:802-812. (Pubitemid 47436127)
18. Blindenbacher A, Wang X, Langer I, Savino R, Terracciano L, Heim MH. Interleukin 6 is important for survival after partial hepatectomy in mice. HEPATOLOGY 2003;38:674-682. (Pubitemid 37052154)
19. Camargo CA, Jr., Madden JF, Gao W, Selvan RS, Clavien PA. Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent. HEPATOLOGY 1997;26:1513-1520. (Pubitemid 27520017)
20. Hong F, Jaruga B, Kim WH, Radaeva S, El-Assal ON, Tian Z, et al. Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS. J Clin Invest 2002;110:1503-1513. (Pubitemid 35396921)
21. Louis H, Van Laethem JL, Wu W, Quertinmont E, Degraef C, Van den Berg K, et al. Interleukin-10 controls neutrophilic infiltration, hepatocyte proliferation, and liver fibrosis induced by carbon tetrachloride in mice. HEPATOLOGY 1998;28:1607-1615. (Pubitemid 28549131)
22. Thompson K, Maltby J, Fallowfield J, McAulay M, Millward-Sadler H, Sheron N. Interleukin-10 expression and function in experimental murine liver inflammation and fibrosis. HEPATOLOGY 1998;28:1597-1606. (Pubitemid 28549130)
23. Klein C, Wustefeld T, Assmus U, Roskams T, Rose-John S, Muller M, et al. The IL-6-gp130-STAT3 pathway in hepatocytes triggers liver protection in T cell-mediated liver injury. J Clin Invest 2005;115:860-869. (Pubitemid 40489390)
24. Haga S, Terui K, Zhang HQ, Enosawa S, Ogawa W, Inoue H, et al. Stat3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms. J Clin Invest 2003;112:989-998. (Pubitemid 38056314)
25. Sakamori R, Takehara T, Ohnishi C, Tatsumi T, Ohkawa K, Takeda K, et al. Signal transducer and activator of transcription 3 signaling within hepatocytes attenuates systemic inflammatory response and lethality in septic mice. HEPATOLOGY 2007;46:1564-1573. (Pubitemid 350155538)
26. Takeda K, Clausen BE, Kaisho T, Tsujimura T, Terada N, Forster I, et al. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 1999;10:39-49. (Pubitemid 29077382)
27. Horiguchi N, Wang L, Mukhopadhyay P, Park O, Jeong WI, Lafdil F, et al. Cell type-dependent pro- and anti-inflammatory role of signal transducer and activator of transcription 3 in alcoholic liver injury. Gastroenterology 2008;134:1148-1158. (Pubitemid 351451970)
28. Lafdil F, Wang H, Park O, Zhang W, Moritoki Y, Yin S, Fu XY, et al. Myeloid STAT3 inhibits T cell-mediated hepatitis by regulating T helper 1 cytokine and interleukin-17 production. Gastroenterology 2009;137:2125-2135; doi:10.1053/j.gastro.2009.08.004
29. Lee CK, Raz R, Gimeno R, Gertner R, Wistinghausen B, Takeshita K, et al. STAT3 is a negative regulator of granulopoiesis but is not required for G-CSF-dependent differentiation. Immunity 2002;17:63-72. (Pubitemid 34874619)
30. Chen J, Bao H, Sawyer S, Kunos G, Gao B. Effects of short and long term ethanol on the activation of signal transducer and activator transcription factor 3 in normal and regenerating liver. Biochem Biophys Res Commun 1997;239:666-669. (Pubitemid 27504158)
31. Marques JM, Belza I, Holtmann B, Pennica D, Prieto J, Bustos M. Cardiotrophin-1 is an essential factor in the natural defense of the liver against apoptosis. HEPATOLOGY 2007;45:639-648. (Pubitemid 46450615)
32. Nakamura K, Nonaka H, Saito H, Tanaka M, Miyajima A. Hepatocyte proliferation and tissue remodeling is impaired after liver injury in oncostatin M receptor knockout mice. HEPATOLOGY 2004;39:635-644. (Pubitemid 38337643)
33. Radaeva S, Sun R, Pan HN, Hong F, Gao B. Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. HEPATOLOGY 2004;39:1332-1342. (Pubitemid 38569055)
34. Reiberger T, Aberle JH, Kundi M, Kohrgruber N, Rieger A, Gangl A, et al. IP-10 correlates with hepatitis C viral load, hepatic inflammation and fibrosis and predicts hepatitis C virus relapse or non-response in HIV-HCV coinfection. Antivir Ther 2008;13:969-976.